Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer

Clinical Cancer Research

Volumn 9, Issue 6, 2003, Pages 2260-2266

  Sienel, Wulf ^a,b,d   Dango, Sebastian ^a   Woelfle, Ute ^c   Morresi Hauf, Alicia ^b   Wagener, Christoph ^c   Brümmer, Jens ^c   Mutschler, Wolf ^a   Passlick, Bernward ^a,b   Pantel, Klaus ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Asklepios Fachklin Munchen Gauting ^*  (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CEACAM 1 ANTIBODY 4D1; CEACAM 1 ANTIBODY C2; CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BRONCHIOLE; CANCER GROWTH; CANCER STAGING; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED;

EID: 0038514856     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., and Edwards, B. K. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst. (Bethesda), 93: 824-842, 2001.
2. Greenlee, R. T., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 2000. CA Cancer J. Clin., 50: 7-33, 2000.
3. Janssen-Heijnen, M. L., Gatta, G., Forman, D., Capocaccia, R., and Coebergh, J. W. Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur. J. Cancer, 34: 2191-2196, 1998.
4. el Torky, M., el Zeky, F., and Hall, J. C. Significant changes in the distribution of histologic types of lung cancer. A review of 4928 cases. Cancer (Phila.), 65: 2361-2367, 1990.
5. Martini, N., Bains, M. S., Burt, M. E., Zakowski, M. F., McCormack, P., Rusch, V. W., and Ginsberg, R. J. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J. Thorac. Cardiovasc. Surg., 109: 120-129, 1995.
6. Mountain, C. F. Revisions in the International System for Staging Lung Cancer. Chest, 111: 1710-1717, 1997.
7. Cavallaro, U., and Christofori, G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta, 1552: 39-45, 2001.
8. Pignatelli, M., and Vessey, C. J. Adhesion molecules: novel molecular tools in tumor pathology. Hum. Pathol., 25: 849-856, 1994.
9. Rojas, M., Fuks, A., and Stanners, C. P. Biliary glycoprotein, a member of the immunoglobulin supergene family, functions in vitro as a Ca2(+)-dependent intercellular adhesion molecule. Cell Growth Differ., 1: 527-533, 1990.
10. Beauchemin, N., Draber, P., Dveksler, G., Gold, P., Gray-Owen, S., Grunert, F., Hammarstrom, S., Holmes, K. V., Karlsson, A., Kuroki, M., Lin, S. H., Lucka, L., Najjar, S. M., Neumaier, M., Obrink, B., Shively, J. E., Skubitz, K. M., Stanners, C. P., Thomas, P., Thompson, J. A., Virji, M., von Kleist, S., Wagener, C., Watt, S., and Zimmermann, W. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res., 252: 243-249, 1999.
11. Turbide, C., Rojas, M., Stanners, C. P., and Beauchemin, N. A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. J. Biol. Chem., 266: 309-315, 1991.
12. Prall, F., Nollau, P., Neumaier, M., Haubeck, H. D., Drzeniek, Z., Helmchen, U., Loning, T., and Wagener, C. CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J. Histochem. Cytochem., 44: 35-41, 1996.
13. Poy, M. N., Yang, Y., Rezaei, K., Fernstrom, M. A., Lee, A. D., Kido, Y., Erickson, S. K., and Najjar, S. M. CEACAM1 regulates insulin clearance in liver. Nat. Genet., 30: 270-276, 2002.
14. Riethdorf, L., Lisboa, B. W., Henkel, U., Naumann, M., Wagener, C., and Loning, T. Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J. Histochem. Cytochem., 45: 957-963, 1997.
15. Luo, W., Tapolsky, M., Earley, K., Wood, C. G., Wilson, D. R., Logothetis, C. J., and Lin, S. H. Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther., 6: 313-321, 1999.
16. Neumaier, M., Paululat, S., Chan, A., Matthaes, P., and Wagener, C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA, 90: 10744-10748, 1993.
17. Bamberger, A. M., Riethdorf, L., Nollau, P., Naumann, M., Erdmann, I., Gotze, J., Brummer, J., Schulte, H. M., Wagener, C., and Loning, T. Dysregulated expression of CD66a (BGP. C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am. J. Pathol., 152: 1401-1406, 1998.
18. Thies, A., Moll, I., Berger, J., Wagener, C., Brummer, J., Schulze, H. J., Brunner, G., and Schumacher, U. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J. Clin. Oncol., 20: 2530-2536, 2002.
19. Ergun, S., Kilik, N., Ziegeler, G., Hansen, A., Nollau, P., Gotze, J., Wurmbach, J. H., Horst, A., Weil, J., Fernando, M., and Wagener, C. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol. Cell, 5: 311-320, 2000.
20. Stoffel, A., Neumaier, M., Gaida, F. J., Fenger, U., Drzeniek, Z., Haubeck, H. D., and Wagener, C. Monoclonal, anti-domain and antipeptide antibodies assign the molecular weight 160,000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family. J. Immunol., 150: 4978-4984, 1993.
21. Altman, D. G., Lausen, B., Sauerbrei, W., and Schumacher, M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. Natl. Cancer Inst. (Bethesda), 86: 829-835, 1994.
22. Kleinbaum, D. G. Survival Analysis, Ed. 1, pp. 83-115. New York: Springer, 1995.
23. Huang, J., Simpson, J. F., Glackin, C., Riethorf, L., Wagener, C., and Shively, J. E. Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells. Anticancer Res., 18: 3203-3212, 1998.
24. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 98: 13790-13795, 2001.
25. Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., Altman, R. B., Brown, P. O., Botstein, D., and Petersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 98: 13784-13789, 2001.